These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 15708180

  • 1. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation.
    Lai WT, Lee KT, Chu CS, Voon WC, Yen HW, Tsai LY, Sheu SH.
    Int J Cardiol; 2005 Feb 28; 98(3):459-64. PubMed ID: 15708180
    [Abstract] [Full Text] [Related]

  • 2. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
    Stefanadi E, Tousoulis D, Antoniades C, Katsi V, Bosinakou E, Vavuranakis E, Triantafyllou G, Marinou K, Tsioufis C, Papageorgiou N, Latsios G, Stefanadis C.
    Int J Cardiol; 2009 Apr 03; 133(2):266-8. PubMed ID: 18187214
    [Abstract] [Full Text] [Related]

  • 3. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
    Goicoechea M, de Vinuesa SG, Lahera V, Cachofeiro V, Gómez-Campderá F, Vega A, Abad S, Luño J.
    J Am Soc Nephrol; 2006 Dec 03; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
    [Abstract] [Full Text] [Related]

  • 4. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M, DISCOVERY PENTA investigators.
    Curr Med Res Opin; 2005 Aug 03; 21(8):1307-15. PubMed ID: 16083541
    [Abstract] [Full Text] [Related]

  • 5. Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women.
    Ushiroyama T, Nosaka S, Ueki M.
    Int J Cardiol; 2006 Oct 26; 113(1):66-75. PubMed ID: 16356567
    [Abstract] [Full Text] [Related]

  • 6. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1035-42. PubMed ID: 17349882
    [Abstract] [Full Text] [Related]

  • 7. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.
    Tousoulis D, Bosinakou E, Kotsopoulou M, Antoniades C, Katsi V, Stefanadis C.
    Int J Cardiol; 2006 Jan 26; 106(3):333-7. PubMed ID: 16337041
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 9. Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Int J Cardiol; 2004 Mar 10; 94(1):111-7. PubMed ID: 14996484
    [Abstract] [Full Text] [Related]

  • 10. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
    Sakabe K, Fukuda N, Fukuda Y, Wakayama K, Nada T, Morishita S, Shinohara H, Tamura Y.
    Nutr Metab Cardiovasc Dis; 2008 Mar 10; 18(3):182-8. PubMed ID: 17399968
    [Abstract] [Full Text] [Related]

  • 11. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S, Schneider MP, Delles C, Jacobi J, Schmieder RE.
    Am Heart J; 2005 Mar 10; 149(3):473. PubMed ID: 15864218
    [Abstract] [Full Text] [Related]

  • 12. Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects.
    Bruni F, Pasqui AL, Pastorelli M, Bova G, Di Renzo M, Cercigani M, Leo A, Auteri A, Puccetti L.
    Int J Cardiol; 2004 Jun 10; 95(2-3):269-74. PubMed ID: 15193831
    [Abstract] [Full Text] [Related]

  • 13. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Am J Cardiol; 2004 Aug 15; 94(4):497-500. PubMed ID: 15325939
    [Abstract] [Full Text] [Related]

  • 14. Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia.
    Nawawi H, Osman NS, Yusoff K, Khalid BA.
    Horm Metab Res; 2003 Aug 15; 35(8):479-85. PubMed ID: 12953165
    [Abstract] [Full Text] [Related]

  • 15. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 15; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.
    Clin Ther; 2007 Nov 15; 29(11):2365-73. PubMed ID: 18158077
    [Abstract] [Full Text] [Related]

  • 17. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
    Bayés B, Granada ML, Lauzurica R, Pastor MC, Navarro M, Bonet J, Llopis MA, Romero R.
    Transplant Proc; 2005 Nov 15; 37(9):3808-12. PubMed ID: 16386546
    [Abstract] [Full Text] [Related]

  • 18. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
    Dogra GK, Watts GF, Chan DC, Stanton K.
    Diabet Med; 2005 Mar 15; 22(3):239-42. PubMed ID: 15717868
    [Abstract] [Full Text] [Related]

  • 19. Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia.
    Chu CS, Lee KT, Lee MY, Su HM, Voon WC, Sheu SH, Lai WT.
    Acta Cardiol; 2006 Jun 15; 61(3):263-9. PubMed ID: 16869445
    [Abstract] [Full Text] [Related]

  • 20. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial.
    Päivä H, Thelen KM, Van Coster R, Smet J, De Paepe B, Mattila KM, Laakso J, Lehtimäki T, von Bergmann K, Lütjohann D, Laaksonen R.
    Clin Pharmacol Ther; 2005 Jul 15; 78(1):60-8. PubMed ID: 16003294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.